Blocking CB1 Receptor Loss Did Not Eliminate Acute THC Responses in a Mouse Experiment
A molecular intervention disrupted THC tolerance in mice while preserving acute drug responses. Preventing adaptation is therefore different from blocking THC’s immediate effects.
From cells to a defined brain circuit
The researchers combined engineered cells, neuronal preparations, mouse experiments and circuit-specific receptor rescue. They investigated how the protein-tagging process called ubiquitination directs CB1 receptors toward proteasomal degradation. The E3 ligase NEDD4L was identified as part of that pathway.
The receptor modification mattered
Preventing ubiquitination of selected receptor sites stabilized receptor protein. In a circuit-specific mouse model, mutant receptors restored acute THC-related catalepsy but impaired the development of tolerance with repeated exposure. Preserved acute responsiveness was an important part of the result.
Receptor turnover is not a diagnosis
The experiments measured receptor protein, signaling and selected behaviors. Degradation of a receptor protein should not be relabeled as evidence that a brain cell died or that a person developed a neurological disorder. Likewise, a molecular mechanism of tolerance does not by itself diagnose cannabis use disorder.
The treatment question is still open
These were preclinical manipulations, including genetic and viral-vector approaches, rather than a tested medicine for cannabis users. Supplementary methods contain additional experimental detail; the main findings do not establish a safe human intervention or a way to reverse impairment after consumption. The research identifies a mechanism for further investigation while preserving the distinction between acute drug action and adaptation to repeated exposure.
Related analysis: evaluating cannabis tolerance claims.
Primary research
Álvaro-Blázquez A; Rodrigues RS; Montero-Fernández C; Isasa M; Cannich A; Gisquet D; Rodríguez-Crespo I; Bellocchio L; Marsicano G; Costas-Insua C; Guzmán M. Cannabinoid tolerance relies on CB1 receptor ubiquitination by NEDD4L. Proceedings of the National Academy of Sciences of the United States of America (2026). DOI: 10.1073/pnas.2606671123.
